Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO)
CUSIP: 869367102
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 84,733,230
- Total 13F shares
- 55,648,249
- Share change
- -706,730
- Total reported value
- $238,729,642
- Put/Call ratio
- 65%
- Price per share
- $4.29
- Number of holders
- 113
- Value change
- -$219,480
- Number of buys
- 60
- Number of sells
- 43
Quarterly Holders Quick Answers
What is CUSIP 869367102?
CUSIP 869367102 identifies STRO - Sutro Biopharma, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 869367102:
Top shareholders of STRO - Sutro Biopharma, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
7.1%
|
5,986,600
|
$20,773,501 | — | 30 Sep 2023 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
6.9%
|
5,883,693
|
$20,416,415 | — | 30 Sep 2023 | |
| BVF INC/IL |
13F
|
Company |
4%
|
3,347,946
|
$11,617,373 | — | 30 Sep 2023 | |
| Rubric Capital Management LP |
13F
|
Company |
3.9%
|
3,344,810
|
$11,606,491 | — | 30 Sep 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3.7%
|
3,105,132
|
$10,774,808 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.4%
|
2,868,762
|
$9,954,604 | — | 30 Sep 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
3.3%
|
2,834,361
|
$9,835,232 | — | 30 Sep 2023 | |
| Verition Fund Management LLC |
13F
|
Company |
3%
|
2,501,676
|
$8,680,816 | — | 30 Sep 2023 | |
| Holocene Advisors, LP |
13F
|
Company |
2.5%
|
2,132,873
|
$7,401,069 | — | 30 Sep 2023 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
2.2%
|
1,867,654
|
$6,480,759 | — | 30 Sep 2023 | |
| Samsara BioCapital, LLC |
13F
|
Company |
2%
|
1,675,579
|
$5,814,259 | — | 30 Sep 2023 | |
| Kynam Capital Management, LP |
13F
|
Company |
1.8%
|
1,552,675
|
$5,387,782 | — | 30 Sep 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
1.8%
|
1,538,234
|
$5,337,672 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.5%
|
1,239,251
|
$4,300,201 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
1,197,152
|
$4,154,605 | — | 30 Sep 2023 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
1.4%
|
1,182,168
|
$4,102,123 | — | 30 Sep 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.3%
|
1,129,823
|
$3,920,696 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
1.3%
|
1,105,785
|
$3,837,074 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.3%
|
1,091,391
|
$3,787,127 | — | 30 Sep 2023 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.92%
|
780,000
|
$2,706,600 | — | 30 Sep 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.91%
|
773,867
|
$2,684,000 | — | 30 Sep 2023 | |
| Eversept Partners, LP |
13F
|
Company |
0.91%
|
769,638
|
$2,670,644 | — | 30 Sep 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.63%
|
533,149
|
$1,850,027 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.57%
|
485,822
|
$1,685,802 | — | 30 Sep 2023 | |
| Vontobel Holding Ltd. |
13F
|
Company |
0.53%
|
450,339
|
$1,562,676 | — | 30 Sep 2023 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.51%
|
432,339
|
$1,500,216 | — | 30 Sep 2023 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.51%
|
430,000
|
$1,492,100 | — | 30 Sep 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.5%
|
425,691
|
$1,477,148 | — | 30 Sep 2023 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.44%
|
369,148
|
$1,280,944 | — | 30 Sep 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.42%
|
355,000
|
$1,231,850 | — | 30 Sep 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.39%
|
330,000
|
$1,145,100 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.36%
|
302,897
|
$1,051,000 | — | 30 Sep 2023 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.33%
|
283,079
|
$982,284 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.31%
|
261,451
|
$907,235 | — | 30 Sep 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.25%
|
212,145
|
$736,143 | — | 30 Sep 2023 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.23%
|
196,517
|
$681,913 | — | 30 Sep 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.22%
|
185,200
|
$642,644 | — | 30 Sep 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.19%
|
160,876
|
$558,240 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.18%
|
153,255
|
$531,794 | — | 30 Sep 2023 | |
| Trevor Hallam |
3/4/5
|
Pres. Rsrch & Cf. Sctific Ofcr |
—
mixed-class rows
|
107,868
mixed-class rows
|
$507,563 | — | 14 Apr 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.14%
|
120,405
|
$417,805 | — | 30 Sep 2023 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.14%
|
120,000
|
$416,400 | — | 30 Sep 2023 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.14%
|
116,000
|
$402,520 | — | 30 Sep 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.13%
|
108,595
|
$376,823 | — | 30 Sep 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.12%
|
105,580
|
$366,363 | — | 30 Sep 2023 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.12%
|
104,990
|
$364,315 | — | 30 Sep 2023 | |
| Arturo Molina MD |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
127,236
mixed-class rows
|
$354,016 | — | 04 Mar 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.11%
|
91,898
|
$318,877 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.11%
|
89,992
|
$312,273 | — | 30 Sep 2023 | |
| Tejara Capital Ltd |
13F
|
Company |
0.1%
|
88,682
|
$307,727 | — | 30 Sep 2023 |
Institutional Holders of Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO) as of Q4 2023
As of 31 Dec 2023,
Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO) was held by
113 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,648,249 shares.
The largest 10 holders included
BlackRock Inc., SUVRETTA CAPITAL MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BVF INC/IL, Rubric Capital Management LP, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, Kynam Capital Management, LP, BAILLIE GIFFORD & CO, and Samsara BioCapital, LLC.
This page lists
113
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
108
Q4 2023 holders
113
Holder diff
5
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.